Can any of the company-specific risk be diversified away by investing in both ASTELLAS PHARMA and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ASTELLAS PHARMA and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ASTELLAS PHARMA UNSPADR and Roche Holding Ltd, you can compare the effects of market volatilities on ASTELLAS PHARMA and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ASTELLAS PHARMA with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of ASTELLAS PHARMA and Roche Holding.
Diversification Opportunities for ASTELLAS PHARMA and Roche Holding
The 3 months correlation between ASTELLAS and Roche is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding ASTELLAS PHARMA UNSPADR and Roche Holding Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding and ASTELLAS PHARMA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ASTELLAS PHARMA UNSPADR are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding has no effect on the direction of ASTELLAS PHARMA i.e., ASTELLAS PHARMA and Roche Holding go up and down completely randomly.
Pair Corralation between ASTELLAS PHARMA and Roche Holding
Assuming the 90 days trading horizon ASTELLAS PHARMA UNSPADR is expected to under-perform the Roche Holding. In addition to that, ASTELLAS PHARMA is 1.14 times more volatile than Roche Holding Ltd. It trades about -0.04 of its total potential returns per unit of risk. Roche Holding Ltd is currently generating about -0.01 per unit of volatility. If you would invest 3,374 in Roche Holding Ltd on March 6, 2024 and sell it today you would lose (380.00) from holding Roche Holding Ltd or give up 11.26% of portfolio value over 90 days.
Over the last 90 days ASTELLAS PHARMA UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Compared to the overall equity markets, risk-adjusted returns on investments in Roche Holding Ltd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Roche Holding is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.